Paul Lin
Overview
Explore the profile of Paul Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin P, Doza A, Gurney Z, Rodriguez G, Mahmoudi E
Arch Phys Med Rehabil
. 2025 Feb;
PMID: 40015497
Objective: To examine trends in healthcare use and cost before and after incident TSCI in the U.S. Design: Retrospective cohort study SETTING: Using 2012-2019 claims data from the Health Care...
2.
Health Care Resource Use and Costs After Hospitalization With Multiple Organ Dysfunction in Children
Odetola F, Lin P, Ye W, Dombkowski K, Linden A
JAMA Netw Open
. 2025 Jan;
8(1):e2456246.
PMID: 39878981
Importance: Multiple organ dysfunction (MOD) is a leading cause of in-hospital child mortality. For survivors, posthospitalization health care resource use and costs are unknown. Objective: To evaluate longitudinal health care...
3.
Melo Garcia L, Gangadharan A, Banerjee P, Li Y, Zeng A, Rafei H, et al.
Cell Rep
. 2025 Jan;
44(1):115122.
PMID: 39754720
CD226 plays a vital role in natural killer (NK) cell cytotoxicity, interacting with its ligands CD112 and CD155 to initiate immune synapse formation, primarily through leukocyte function-associated-1 (LFA-1). Our study...
4.
Pasvolsky O, Marcoux C, Wang Z, Milton D, Pal B, Tanner M, et al.
Transplant Cell Ther
. 2025 Jan;
31(3):166.e1-166.e9.
PMID: 39746546
Patients with multiple myeloma (MM) without high-risk cytogenetic abnormalities are classified as having standard-risk MM (SRMM), and data focusing on their outcomes after autologous hematopoietic stem cell transplantation (autoHCT) are...
5.
Marcoux C, Pasyar S, Milton D, Khan H, Tanner M, Bashir Q, et al.
Br J Haematol
. 2024 Nov;
206(2):763-765.
PMID: 39610225
No abstract available.
6.
Pasvolsky O, Marcoux C, Milton D, Pal B, Tanner M, Bashir Q, et al.
Blood Cancer J
. 2024 Nov;
14(1):189.
PMID: 39482325
Autologous transplantation remains the standard of care for eligible multiple myeloma (MM) patients, yet optimal CD34 cell dose remains unclear. We conducted a retrospective study on MM patients undergoing upfront...
7.
Marcoux C, Pasvolsky O, Milton D, Tanner M, Bashir Q, Srour S, et al.
Transplant Cell Ther
. 2024 Oct;
31(1):12.e1-12.e10.
PMID: 39448031
Despite tremendous advancements in multiple myeloma (MM) therapeutics, outcomes remain heterogeneous, heavily influenced by clinical and cytogenetic factors. Among these, deletion of the short arm of chromosome 17 (del(17p)) is...
8.
Kumar B, Singh A, Basar R, Uprety N, Li Y, Fan H, et al.
Sci Transl Med
. 2024 Sep;
16(764):eadp0004.
PMID: 39259809
Myelodysplastic syndrome and acute myeloid leukemia (AML) belong to a continuous disease spectrum of myeloid malignancies with poor prognosis in the relapsed/refractory setting necessitating novel therapies. Natural killer (NK) cells...
9.
Lin P, Kamdar N, Rodriguez G, Cigolle C, Tate D, Mahmoudi E
Spinal Cord
. 2024 Jun;
62(8):479-485.
PMID: 38937544
Study Design: Retrospective case/control longitudinal cohort study OBJECTIVES: Prevalent traumatic spinal cord injury (TSCI) is associated with Alzheimer's disease and related dementia (ADRD). We examined the hazard ratio for ADRD...
10.
Acharya S, Basar R, Daher M, Rafei H, Li P, Uprety N, et al.
Cancer Discov
. 2024 Jun;
14(10):1879-1900.
PMID: 38900051
Multiple factors in the design of a chimeric antigen receptor (CAR) influence CAR T-cell activity, with costimulatory signals being a key component. Yet, the impact of costimulatory domains on the...